Nancy Sambol, PharmD
Professor
Bioengineering
School of Pharmacy

Education & Training

Show all (3) Hide

• Fellowship Pharmacy University of California, San Francisco 1986
• Pharm.D. School of Pharmacy University of Texas 1983
• B.S. Pharmacy School of Pharmacy University of Illinois 1981

Publications (24)

Top publication keywords:
Antithrombin IIIGastric BypassFibrinolytic AgentsQuinolinesAntimalarialsMalaria, FalciparumLevonorgestrelEnoxaparinMetforminHypoglycemic AgentsChemopreventionContraceptives, Oral, SyntheticAnalgesicsMalariaArtemisinins

• Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis.
  PLoS medicine 2017 Hoglund RM, Workman L, Edstein MD, Thanh NX, Quang NN, Zongo I, Ouedraogo JB, Borrmann S, Mwai L, Nsanzabana C, Price RN, Dahal P, Sambol NC, Parikh S, Nosten F, Ashley EA, Phyo AP, Lwin KM, McGready …
• Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria.
  The Journal of infectious diseases 2016 Tchaparian E, Sambol NC, Arinaitwe E, McCormack SA, Bigira V, Wanzira H, Muhindo M, Creek DJ, Sukumar N, Blessborn D, Tappero JW, Kakuru A, Bergqvist Y, Aweeka FT, Parikh S
• Rethinking Dosing Regimen Selection of Piperaquine for Malaria Chemoprevention: A Simulation Study.
  PloS one 2016 Sambol NC, Tappero JW, Arinaitwe E, Parikh S
• Population Pharmacokinetics of Piperaquine in Young Ugandan Children Treated With Dihydroartemisinin-Piperaquine for Uncomplicated Malaria.
  Clinical pharmacology and therapeutics 2015 Sambol NC, Yan L, Creek DJ, McCormack SA, Arinaitwe E, Bigira V, Wanzira H, Kakuru A, Tappero JW, Lindegardh N, Tarning J, Nosten F, Aweeka FT, Parikh S
• CYP2A6 genotype but not age determines cotinine half-life in infants and children.
  Clinical pharmacology and therapeutics 2013 Dempsey DA, Sambol NC, Jacob P, Hoffmann E, Tyndale RF, Fuentes-Afflick E, Benowitz NL

Show all (19 more) Hide

• Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity.
  Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery 2008 Borkgren-Okonek MJ, Hart RW, Pantano JE, Rantis PC, Guske PJ, Kane JM, Gordon N, Sambol NC
• Pharmacokinetics of single-dose levonorgestrel in adolescents.
  Contraception 2006 Sambol NC, Harper CC, Kim L, Liu CY, Darney P, Raine TR
• Plasma pharmacokinetics and tissue biodistribution of boron following administration of a boronated porphyrin in dogs.
  Journal of pharmaceutical sciences 2000 Tibbitts J, Sambol NC, Fike JR, Bauer WF, Kahl SB
• Pharmacodynamic analysis of analgesic clinical trials: nonlinear mixed-effects logistic models.
  Journal of biopharmaceutical statistics 1999 Liu CY, Sambol NC
• Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin-dependent diabetes mellitus.
  Journal of clinical pharmacology 1996 Sambol NC, Chiang J, O'Conner M, Liu CY, Lin ET, Goodman AM, Benet LZ, Karam JH
• Food intake and dosage level, but not tablet vs solution dosage form, affect the absorption of metformin HCl in man.
  British journal of clinical pharmacology 1996 Sambol NC, Brookes LG, Chiang J, Goodman AM, Lin ET, Liu CY, Benet LZ
• In vitro-in vivo relationship of oral extended-release dosage forms.
  Pharmaceutical research 1996 Liu FY, Sambol NC, Giannini RP, Liu CY
• Kidney function and age are both predictors of pharmacokinetics of metformin.
  Journal of clinical pharmacology 1995 Sambol NC, Chiang J, Lin ET, Goodman AM, Liu CY, Benet LZ, Cogan MG
• Felodipine population dose-response and concentration-response relationships in patients with essential hypertension.
  Clinical pharmacology and therapeutics 1995 Wade JR, Sambol NC
• Pharmacokinetics of oral extended-release dosage forms. I. Release kinetics, concentration, and absorbed fraction.
  Pharmaceutical research 1995 Liu FY, Sambol NC, Giannini RP, Liu CY
• Pharmacodynamic analysis of analgesic clinical trials using empirical methods.
  Pharmaceutical research 1995 Liu CY, Sambol NC
• Interaction between structural, statistical, and covariate models in population pharmacokinetic analysis.
  Journal of pharmacokinetics and biopharmaceutics 1994 Wade JR, Beal SL, Sambol NC
• Variational analysis of the transdermal delivery rate from two prototypical ethanol-water nitroglycerin TTS devices and Transderm-Nitro 10 in the normal population.
  Journal of pharmacokinetics and biopharmaceutics 1992 Kochak GM, Berner B, Leal M, Sambol NC
• Population dose versus response of betaxolol and atenolol: a comparison of potency and variability.
  Clinical pharmacology and therapeutics 1991 Sambol NC, Sheiner LB
• Effect of hydrochlorothiazide 25 mg/day on essential hypertension.
  Clinical pharmacy 1990 Sambol NC, Bostrom A, Williams RL
• Pharmacokinetics, pharmacodynamics, and minimum effective clinical dose of intravenous nicardipine.
  Clinical pharmacology and therapeutics 1990 Cook E, Clifton GG, Vargas R, Bienvenu G, Williams R, Sambol N, McMahon G, Grandy S, Lai CM, Quon C
• Study designs for dose-ranging.
  Clinical pharmacology and therapeutics 1989 Sheiner LB, Beal SL, Sambol NC
• A comparison of the influence of famotidine and cimetidine on phenytoin elimination and hepatic blood flow.
  British journal of clinical pharmacology 1989 Sambol NC, Upton RA, Chremos AN, Lin ET, Williams RL
• Sequential infusions of methotrexate and 5-fluorouracil in advanced cancer: pharmacology, toxicity, and response.
  Cancer research 1985 Benz C, DeGregorio M, Saks S, Sambol N, Holleran W, Ignoffo R, Lewis B, Cadman E